Pacira生物科学公司发布了一项真实世界研究，结果显示，在全肩关节置换术患者中使用其非阿片类镇痛药Exparel®，与减少阿片类药物使用和降低医疗成本相关。该研究数据进一步支持了Exparel在术后疼痛管理中的价值，可能为患者和医疗系统带来双重益处。
Pacira生物科学公司发布了一项真实世界研究，结果显示，在全肩关节置换术患者中使用其非阿片类镇痛药Exparel®，与减少阿片类药物使用和降低医疗成本相关。该研究数据进一步支持了Exparel在术后疼痛管理中的价值，可能为患者和医疗系统带来双重益处。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.